PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29303508-0	2018	Glutamine synthetase mediates sorafenib sensitivity in beta-catenin-active hepatocellular carcinoma cells.	Sorafenib	30-39	glutamate-ammonia ligase	Homo sapiens	0-20	
29303508-7	2018	Our results demonstrated that glutamine synthetase-mediated autophagy explains the high sensitivity of beta-catenin-active hepatocellular carcinoma cells to sorafenib.	Sorafenib	157-166	glutamate-ammonia ligase	Homo sapiens	30-50	
22811581-9	2012	In addition, sorafenib attenuated expression of liver-related Wnt-targets GLUL, LGR5, and TBX3.	Sorafenib	13-22	glutamate-ammonia ligase	Homo sapiens	74-78